1.1500
05-November-24 14:59:03
15 minutes delayed
Stocks
-0.0200
-1.71%
Today's range
1.1401 - 1.1900
ISIN
N/A
Source
NASDAQ
Indaptus Therapeutics to Present at Two Upcoming Investor Conferences
23 Oct 2024 07:00:01 By Nasdaq GlobeNewswire
Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations
22 Oct 2024 07:00:01 By Nasdaq GlobeNewswire
Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data
15 Oct 2024 07:00:00 By Nasdaq GlobeNewswire